Allan Bukuya has joined the Triall initiative as Advisor eClinical Solutions. He brings two decades of experience in clinical research and in-depth understanding of the Pharma, CRO and eClinical industries. Allan is the founder of TrialDocs, a clinical trial services company that offers eClinical solutions for document management to clinical trial sites, empowering researchers to better […]
In a previous article, we introduced clinical trials and explained why they are so important to our health systems. In this article, we will address how blockchain technology can play a fundamental role in tackling some of the persisting issues that make today’s clinical trials overly complex, lengthy and resource-inefficient. This article is the first in […]
Danielle Bradbury will join the Triall initiative as advisor Quality and Compliance. She has over 20 years of experience in clinical research and has extensive knowledge of SOP management, GxP inspection readiness, computer system validation, and quality compliance. Danielle currently is Head of Quality Assurance at Galera Therapeutics where she provides senior strategic quality leadership ensuring […]
Sina Djali will join the ranks of the Triall initiative as advisor Clinical Trial Data Analytics. Sina has over 25 years of experience in drug and clinical development in various companies and academia. Sina Djali currently is the Head of Integrated Clinical and Operational Analytics in Enabling Business and Information Solutions at Janssen (a pharmacuetical […]
We are excited to announce the world’s first clinical trial on the blockchain. A beta version of the foundation’s Verial software application was given green light for use in a real-world clinical trial and is now live in production, following positive assessment of its compliance with international regulations and quality standards for medical research. This marks […]
A steady and efficient influx of novel medical solutions is critical for meeting society’s current and future medical needs. The clinical research industry is responsible for the delivery of these solutions to society by systematically evaluating their safety and efficacy in so-called clinical trials. But what do clinical trials exactly entail and why are they […]
Triall today announces that it has received funding as part of the second Factom grant round of 2019. It will use these funds to develop a Factom-enabled Decentralized Identifier (DID) functionality within Triall’s electronic Trial Master File (eTMF) application. The Factom community provides financial support to parties innovating on top of the Factom Protocol through […]
Biopharmaceutical companies, Contract Research Organizations (CROs) and research sites are increasingly using clinical trial IT (‘eClinical’) solutions to smoothen and optimize the management and conduct of their clinical trial activities. As a result, the global eClinical market is expected to register an impressive CAGR of 13,6% over the coming years, reaching $12 billion by 2025. […]
The National eHealth Living Lab (NeLL) originated in the Leiden University Medical Center and is one of the main partners of Triall. At NeLL, patients, healthcare professionals, consumers, students, scientists, entrepreneurs, organizations, and institutions corporate to develop and create successful eHealth-tools. NeLL strives to be an open, independent, knowledge-driven eHealth community. According to NeLL: eHealth […]
Triall today announces that it will be presenting at the ClinOpsDag 2019 (‘Clinical Operations Day’) event on the 15th of May. As part of the event, Joost Flach, Triall’s director of clinical affairs, will be giving an educational workshop on the possible implementations of blockchain technology in clinical trials. The ClinOpsDag is hosted by the […]